The Vox Markets Podcast / Tim Watts, CEO of Shield Therapeutics #STX provides a U.S. update and confirms they remain on track to launch Accrufer® in the US by the end of June 2021.

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.